A detailed history of Octagon Capital Advisors LP transactions in Insmed Inc stock. As of the latest transaction made, Octagon Capital Advisors LP holds 250,000 shares of INSM stock, worth $17 Million. This represents 3.87% of its overall portfolio holdings.

Number of Shares
250,000
Previous 1,140,000 78.07%
Holding current value
$17 Million
Previous $30.9 Million 45.84%
% of portfolio
3.87%
Previous 4.84%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$22.0 - $69.71 $10.8 Million - $34.1 Million
-489,784 Reduced 42.96%
650,216 $43.6 Million
Q1 2024

May 15, 2024

SELL
$25.72 - $29.94 $3.7 Million - $4.31 Million
-144,000 Reduced 11.21%
1,140,000 $30.9 Million
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $21.5 Million - $29.1 Million
917,000 Added 249.86%
1,284,000 $39.8 Million
Q2 2023

Aug 14, 2023

BUY
$16.44 - $21.1 $6.03 Million - $7.74 Million
367,000 New
367,000 $7.74 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.22B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.